• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The impact of rapid molecular diagnostic testing for respiratory viruses on outcomes for emergency department patients

tetano

Editor, Senior Moderator
Med J Aust. 2019 Mar 5. doi: 10.5694/mja2.50049. [Epub ahead of print]
[h=1]The impact of rapid molecular diagnostic testing for respiratory viruses on outcomes for emergency department patients.[/h] Wabe N[SUP]1[/SUP], Li L[SUP]1[/SUP], Lindeman R[SUP]2[/SUP], Yimsung R[SUP]2[/SUP], Dahm MR[SUP]1[/SUP], Clezy K[SUP]3[/SUP], McLennan S[SUP]2,[/SUP][SUP]4[/SUP], Westbrook J[SUP]1[/SUP], Georgiou A[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]OBJECTIVE:[/h] To determine whether rapid polymerase chain reaction (PCR) testing for influenza and respiratory syncytial viruses (RSV) in emergency departments (EDs) is associated with better patient and laboratory outcomes than standard multiplex PCR testing.
[h=4]DESIGN, SETTING:[/h] A before-and-after study in four metropolitan EDs in New South Wales.
[h=4]PARTICIPANTS:[/h] 1491 consecutive patients tested by standard multiplex PCR during July-December 2016, and 2250 tested by rapid PCR during July-December 2017.
[h=4]MAIN OUTCOME MEASURES:[/h] Hospital admissions; ED length of stay (LOS); test turnaround time; patient receiving test result before leaving the ED; ordering of other laboratory tests.
[h=4]RESULTS:[/h] Compared with those tested by standard PCR, fewer patients tested by rapid PCR were admitted to hospital (73.3% v 77.7%; P < 0.001) and more received their test results before leaving the ED (67.4% v 1.3%; P < 0.001); the median test turnaround time was also shorter (2.4 h [IQR, 1.6-3.9 h] v 26.7 h [IQR, 21.2-37.8 h]). The proportion of patients admitted to hospital was also lower in the rapid PCR group for both children under 18 (50.6% v 66.6%; P < 0.001) and patients over 60 years of age (84.3% v 91.8%; P < 0.001). Significantly fewer blood culture, blood gas, sputum culture, and respiratory bacterial and viral serology tests were ordered for patients tested by rapid PCR. ED LOS was similar for the rapid (7.4 h; IQR, 5.0-12.9 h) and standard PCR groups (6.5 h; IQR, 4.2-11.9 h; P = 0.27).
[h=4]CONCLUSION:[/h] Rapid PCR testing of ED patients for influenza virus and RSV was associated with better outcomes on a range of indicators, suggesting benefits for patients and the health care system. A formal cost-benefit analysis should be undertaken.
? 2019 The Authors. Medical Journal of Australia published by AMPCo Pty Ltd.


[h=4]KEYWORDS:[/h] Diagnostic tests and procedures; Emergency services, medical; Public health

PMID: 30838671 DOI: 10.5694/mja2.50049
 
Back
Top Bottom